HISTORY OF DCD HEART TRANSPLANTATION
The first human heart transplant, performed by Christiaan Barnard in 1967, was made possible by a DCD donor and a recipient who was located in an operating room adjacent to the donor. 3 This seminal medical achievement was marred in ethical controversy, which led to the Harvard criteria for brain death in 1968. 4 DCD heart transplantation was subsequently abandoned in favor of donation after brain death heart transplantation because DCD hearts were considered inferior out of concern for ischemic injury to the donor heart.
Interest in DCD heart transplantation was rekindled by the dire donor shortage. Among the earliest indicators that the risks of ischemic injury to DCD donor hearts are controllable was a retrospective cohort study analyzing 38 patients transplanted with hearts from donors who had experienced a recent period of cardiac arrest. The mean duration of donor cardiac arrest was 15 minutes, and the mean interval between donor cardiac arrest and transplantation was 69 hours. The 30-day mortality (2.6%; n=1/38) of these patients was not significantly different from 566 patients transplanted during the same time period with hearts that had not arrested in the donor. 5 Moreover, in 2008, the heart of a 53-year-old DCD donor was reanimated using extracorporeal circulatory support after 23 minutes of cardiorespiratory arrest. This effectively converted a DCD heart into a beating donor heart. 6 Based on this work, Dhital et al 7 performed the world's first distantly procured DCD heart transplant in 2014. These breakthroughs catalyzed the establishment of several DCD heart transplantation programs in Europe and Australia, with encouraging early results.
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Donation After Cardiac Death Heart Transplantation in America Is Clinically Necessary and Ethically Justified SURGICAL TECHNIQUES FOR DCD HEART PROCUREMENT
Three different surgical techniques can be used for DCD heart procurement, namely normothermic regional perfusion, 8 direct procurement and perfusion, 7 and procurement from a colocated donor. 9 For all techniques, cardiac death must be declared within minutes from withdrawal of life support to minimize the warm ischemic time.
With normothermic regional perfusion, the cerebral circulation is interrupted by clamping the innominate and carotid arteries to eliminate the theoretical recovery of brain activity after resuscitation. Subsequently, regional cardiopulmonary bypass is instituted to reperfuse and reanimate the heart inside the donor. After return of a cardiac rhythm, the donor is reintubated, and cardiopulmonary bypass is weaned. This effectively converts an arrested DCD heart into a beating donor heart, which is evaluated for transplantation and retrieved in the usual fashion. 8 With direct procurement and perfusion, donor blood is first collected to prime an ex vivo organ perfusion system, such as the TransMedics OCS. The heart is then retrieved from the donor and connected to the ex vivo perfusion system where it is reperfused and reanimated. After return of a cardiac rhythm, the heart is evaluated for transplantation. 7 Finally, with transplantation from a colocated donor, preservation of the arrested heart is initiated using topical cold infusion into the donor. The heart is then recovered in the usual fashion, expeditiously transplanted into the recipient in an adjacent operating room, and then reperfused and reanimated in the recipient using cardiopulmonary bypass.
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DCD HEART TRANSPLANTATION IN AMERICA IS ETHICALLY JUSTIFIED
In the United States, cardiac death is declared on the basis of irreversible cardiac arrest. 2 The Institute of Medicine published a report in 2000 noting that cardiac arrest becomes irreversible within 60 seconds. 10 This defines a time frame for DCD organ procurement. Moreover, the Joint Commission requires that all accredited hospitals have a DCD policy. 11 As a result, there is a robust American experience with DCD transplantation of organs, such as the lungs, livers, and kidneys. However, DCD heart transplantation carries inherent ethical and legal contradictions related to the definition of cardiac death. Reanimation of the donor heart, by any of the 3 surgical techniques described above, proves that donor cardiac arrest had not been irreversible. Opponents of DCD heart transplantation argue that reanimation of the donor heart thus invalidates the donor declaration of cardiac death. This would make the concept of DCD heart transplantation illegal because procurement of vital organs from a living donor is prohibited by the dead donor rule. 12 Although this argument seems legally powerful, it loses its relevance in clinical translation.
First, the act of reanimating the donor heart sometime after declaration of cardiac death does not affect its biological condition at the time when death was declared. Therefore, it is counterintuitive to think that the act of reanimating the donor heart outside the donor body, for example, in an ex vivo perfusion system, could retrospectively toggle the state of the donor between dead and alive.
Second, donors invariably lose brain function because of cerebral ischemia after cardiac arrest. Irreversibility of this loss of brain function despite donor heart reanimation is ensured by clamping the innominate and carotid arteries in the case of normothermic regional perfusion and by removing the heart from the donor before reanimation in the case of the other procurement techniques. Therefore, the donor can be considered brain dead before the donor heart is reanimated.
Third, medical interventions to facilitate organ donation are routinely undertaken after declaration of cardiac death. Similarly, cardiac arrest at the time when death is declared should be considered separate from subsequent efforts to resuscitate the heart specifically for donation. This serves the donor's interest by realizing his or her wish to give the gift of life to the recipient.
Fourth, there are no clinical reasons why DCD hearts should be treated differently from other organs, such as the lungs. The heart is no longer vital in the sense that many patients survive long-term without a native heart on a total artificial heart. Conversely, DCD lungs are routinely transplanted after their function is re-established using an ex vivo lung perfusion system. Fifth, there are no clinical reasons why DCD heart transplantation should be treated differently in European and Australian jurisdictions from America.
Finally, legal definitions of death have evolved to accommodate clinical advances in organ transplantation and end-of-life care. Consequently, it should be possible to further refine the American legal framework to accommodate DCD heart transplantation.
CONCLUSIONS
DCD heart transplantation remains an area of ethical and legal controversy where well-considered judgments differ widely. Because of the dire need for donor hearts, it is clinically necessary to resolve these controversies as soon as possible. The DCD paradigm has the potential to increase overall heart transplantation volume by over 20%. 13, 14 
